Detalhe da pesquisa
1.
Apolipoprotein A1 Infusions and Cardiovascular Outcomes after Acute Myocardial Infarction.
N Engl J Med
; 390(17): 1560-1571, 2024 May 02.
Artigo
Inglês
| MEDLINE | ID: mdl-38587254
2.
Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients.
N Engl J Med
; 388(15): 1353-1364, 2023 Apr 13.
Artigo
Inglês
| MEDLINE | ID: mdl-36876740
3.
Efficacy, Safety, and Tolerability of Inclisiran in Patients With Homozygous Familial Hypercholesterolemia: Results From the ORION-5 Randomized Clinical Trial.
Circulation
; 149(5): 354-362, 2024 01 30.
Artigo
Inglês
| MEDLINE | ID: mdl-37850379
4.
Obicetrapib on Top of Maximally Tolerated Lipid-Modifying Therapies in Participants With or at High Risk for Atherosclerotic Cardiovascular Disease: Rationale and Designs of BROADWAY and BROOKLYN.
Am Heart J
; 2024 May 03.
Artigo
Inglês
| MEDLINE | ID: mdl-38705341
5.
Obicetrapib: Reversing the Tide of CETP Inhibitor Disappointments.
Curr Atheroscler Rep
; 26(2): 35-44, 2024 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-38133847
6.
New Approaches for Targeting PCSK9: Small-Interfering Ribonucleic Acid and Genome Editing.
Arterioscler Thromb Vasc Biol
; 43(7): 1081-1092, 2023 07.
Artigo
Inglês
| MEDLINE | ID: mdl-37259866
7.
Inclisiran for the Treatment of Heterozygous Familial Hypercholesterolemia.
N Engl J Med
; 382(16): 1520-1530, 2020 04 16.
Artigo
Inglês
| MEDLINE | ID: mdl-32197277
8.
Two Phase 3 Trials of Inclisiran in Patients with Elevated LDL Cholesterol.
N Engl J Med
; 382(16): 1507-1519, 2020 04 16.
Artigo
Inglês
| MEDLINE | ID: mdl-32187462
9.
Evolocumab in Pediatric Heterozygous Familial Hypercholesterolemia.
N Engl J Med
; 383(14): 1317-1327, 2020 10 01.
Artigo
Inglês
| MEDLINE | ID: mdl-32865373
10.
Evinacumab for Homozygous Familial Hypercholesterolemia.
N Engl J Med
; 383(8): 711-720, 2020 08 20.
Artigo
Inglês
| MEDLINE | ID: mdl-32813947
11.
The evolving role of cholesteryl ester transfer protein inhibition beyond cardiovascular disease.
Pharmacol Res
; 197: 106972, 2023 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-37898443
12.
Bempedoic Acid for Primary Prevention of Cardiovascular Events in Statin-Intolerant Patients.
JAMA
; 330(2): 131-140, 2023 07 11.
Artigo
Inglês
| MEDLINE | ID: mdl-37354546
13.
Can we revive CETP-inhibitors for the prevention of cardiovascular disease?
Curr Opin Lipidol
; 33(6): 319-325, 2022 12 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36345867
14.
A structurally engineered fatty acid, icosabutate, suppresses liver inflammation and fibrosis in NASH.
J Hepatol
; 76(4): 800-811, 2022 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-34915054
15.
20-Year Follow-up of Statins in Children with Familial Hypercholesterolemia.
N Engl J Med
; 381(16): 1547-1556, 2019 10 17.
Artigo
Inglês
| MEDLINE | ID: mdl-31618540
16.
Mendelian Randomization Study of ACLY and Cardiovascular Disease.
N Engl J Med
; 380(11): 1033-1042, 2019 03 14.
Artigo
Inglês
| MEDLINE | ID: mdl-30865797
17.
Cholesteryl Ester Transfer Protein Inhibition Reduces Major Adverse Cardiovascular Events by Lowering Apolipoprotein B Levels.
Int J Mol Sci
; 23(16)2022 Aug 20.
Artigo
Inglês
| MEDLINE | ID: mdl-36012684
18.
Carotid Intima-Media Thickness Progression as Surrogate Marker for Cardiovascular Risk: Meta-Analysis of 119 Clinical Trials Involving 100 667 Patients.
Circulation
; 142(7): 621-642, 2020 08 18.
Artigo
Inglês
| MEDLINE | ID: mdl-32546049
19.
Rationale and design of ApoA-I Event Reducing in Ischemic Syndromes II (AEGIS-II): A phase 3, multicenter, double-blind, randomized, placebo-controlled, parallel-group study to investigate the efficacy and safety of CSL112 in subjects after acute myocardial infarction.
Am Heart J
; 231: 121-127, 2021 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33065120
20.
Lipid-Reduction Variability and Antidrug-Antibody Formation with Bococizumab.
N Engl J Med
; 376(16): 1517-1526, 2017 04 20.
Artigo
Inglês
| MEDLINE | ID: mdl-28304227